CLINICAL_TRIALS trial_result · 2018-05-07

Clinical Trial Update: Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma [Phase 2]

Phase 2 study of dovitinib in Adenoid Cystic Carcinoma has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Virginia | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-05-07